Printer Friendly

Deal snapshot: FOUR US COMPANIES MERGE TO FORM DISCOVERY LIFE SCIENCES.

MANews-(C)2009-2018

US-based life science companies Conversant Bio, Folio Bio, Discovery Life Sciences and Phylogeny have merged under the name Discovery Life Sciences (Discovery) to create a global firm in biospecimen analysis and procurement for the pharmaceutical, biotechnology and diagnostics industries, the companies said.

The new company will leverage deep scientific expertise and consultative services, combined with the largest repository of more than 10m research-quality biospecimens, all available and processed for analysisa[euro]"to accelerate the discovery, research, and development of novel biomarkers, drug candidates, and diagnostics.

Country: USA

Sector: Biotechnology

Target: Discovery Life Sciences

Buyer: Conversant Bio, Folio Bio, Discovery Life Sciences and Phylogeny

Vendor:

Deal size in USD:

Type: Merger

Financing:

Status: Closed

Buyer advisor: , ,

Comment: Terms of the deal were not disclosed

COPYRIGHT 2018 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M & A Navigator
Date:Oct 17, 2018
Words:126
Previous Article:Deal snapshot: GENERATIONAL EQUITY ADVISES PRESTIGE PROPERTY MAINTENANCE IN SALE TO JUNIPER LANDSCAPING.
Next Article:Deal snapshot: CYBER CONSULTING AND INCIDENT RESPONSE FIRM SVGNIA TO BE ACQUIRED BY SINGAPORE'S TEMASEK.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters